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Abstract
Background: Isocyanates are extensively used in the manufacture of polyurethane foams, plastics,
coatings or adhesives. They are a major cause of occupational asthma in a proportion of exposed
workers. Recent findings in animal models have demonstrated that isocyanate-induced asthma does
not always represent an IgE-mediated sensitization, but still a mixed profile of CD4+ Th1 and TH2,
as well as a CD8+ immune response. Despite immunologic similarities between this pathology and
IgE-mediated food allergies, this co-morbidity is rarely reported.
Case presentation: A 50-year old man employed as vehicle body painter, for 8 years complained
about breathlessness, wheezing, sneezing, nasal obstruction and excessive production of mucus
during the use of DuPont Refinish Centari Tintings – an acrylic enamel tint. Symptoms occurred
15–20 minutes after workplace exposure and usually persisted until evening, or at times, up to two
consecutive days. The above mentioned symptoms were associated with a decrease of lung
functions parameters. The use of inhaled adrenergic bronchio-dilatators and steroids relived the
symptoms.
In addition, three years ago he developed an anaphylactic reaction due to peanut consumption,
experiencing urticaria, angioedema and airway obstruction. He was successfully treated in the
hospital. Later, the subject exhibited labial itching, as well as orbital and perioral angioedema, 20
minutes after stationary performance of challenge test with peanuts.
Evaluating the reported data, this process might be developed rather due to induction of a TH2
profile, because in both cases have occurred IgE-mediated symptoms. A less plausible mechanism
could be the presence of isocyanates in peanuts due to a probable contamination by pesticides
resulting in an allergic reaction after "consumption" of di-isocyanate as long as the isocyanate
contamination of peanuts has not been proven.
Conclusion: Despite the lack of relevant laboratory findings, this might be the first case of
isocyanate-induced occupational asthma described in a patient who developed peanut allergy
symptoms later in his life. However, in order to take further suitable precautions, further studies
are necessary to elucidate the questions posed in this report.
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Background
Isocyanates, widely used in the manufacture of poly-
urethane foams, plastics, coatings, or adhesives, and are
known to cause the most common type of occupational
asthma in a number of exposed workers [1-4]. Addition-
ally, some residents living nearby fiber processing and
polyurethane foam manufacturing facilities become sen-
sitized to toluene di-isiocyanate (TDI) [5].
With respect to pathogenesis, recent findings especially in
animal models demonstrated that isocyanate-induced
asthma does not always represent an IgE-mediated sensi-
tization, but still a mixed profile of CD4+ Th1 and TH2,
as well as CD8+ immune response [2,4,6-10]. Also a com-
bined IL-4/IL-13 depletion in a murine model effectively
prevented almost all asthma pathologic symptoms [4].
Furthermore, Herrick et al. demonstrated that eosi-
nophilic inflammatory processes in the airways were
mediated by TH2 cytokines and not by IFNγ [7,8].
This pathology has an important clinical relevance,
because asthmatic symptoms are developed in 5–15% of
exposed workers and these symptoms may persist even
after complete isocyanate avoidance, perhaps due to met-
alloproteinase MMP-9 overproduction and consequent
induction of airway inflammation and remodeling
[9,11,12]. Apart from the inhalation route of exposure,
many experimental findings in animals have demon-
strated the potential role of dermal contact after isocy-
anate exposure regarding the initial response and
subsequent development of occupational asthma,
whereas the use of latex gloves did not prevent the isocy-
anate sensitization among exposed workers [9,13-16].
Despite some immunologic similarities between this
pathology and IgE-mediated food allergies, this co-mor-
bidity is rarely reported. In effect, peanut allergy occurs
generally in childhood [17]. Because of these facts, the
description of a case of isocyanate-induced occupational
asthma in a patient who developed symptoms of peanut
allergy later in his life could be of great interest.
Case presentation
Our case
A 50-year old man, a former smoker, employed as vehicle
body painter 25 years ago, used to work with an acrylic
enamel tint – DuPont Refinish Centari Tintings. 17 years
later, he began to exhibit urticaria and facial angioedema
after work exposure. These symptoms were resolved after
treatment with antihistamines. The last 8 years he experi-
enced also cough, breathlessness, wheezing, sneezing,
nasal obstruction and excessive production of mucus. The
symptoms occurred 15–20 minutes after exposure to
acrylic enamel tint at the workplace and persisted usually
until the evening, or at times, up to two consecutive days.
The use of inhaled adrenergic bronchio-dilatators and
steroids relived the symptoms within two hours. In fact,
he irregularly used to inhale budesonide in case of clinical
deteriorations. He had used an oronasal mask to avoid
tint for four years. The subject experienced different respi-
ratory obstructive symptoms such as nasal obstruction
and excessive production of mucus, sneezing, as well as
dispnoea and chest tightness, if he discontinued the using
of the face mask at workplace.
Spirometry showed normal ventilatory function in the
non-working days. A significant reduction in forced expir-
atory volume at first second (FEV1) (50%), functional
vital capacity (FVC) (67%) and peak expiratory flow (PEF)
(75%) was observed after work exposure. The above men-
tioned respiratory functional parameters were normalized
after the use of inhalant bronchio-dilatators and steroids.
Consequently, within two hours the symptoms were
resolved. Skin prick tests with common aeroallergens were
negative. Blood test and radiological examinations were
within normal limits. There was no familial history of
atopy.
In addition, three years ago he developed an anaphylactic
reaction due to peanut consumption. The patient mani-
fested classical symptoms of anaphylaxis as urticaria,
angioedema and dispnoea. He showed a marked clinical
improvement only after four hours of treatment in hospi-
tal. Some months later, the patient underwent the oral
challenge test with peanuts and 20 minutes later, he devel-
oped labial itching, as well as orbital and perioral
angioedema. Afterwards, he followed a strict peanut elim-
ination diet. All these findings confirm the diagnoses of
occupational asthma and rhinitis due to isocyanates and
peanut anaphylactic reaction.
Discussion
TDI and diphenyl-methane di-isocyanate (DMI), used as
drying accelerator of Centari tint, are widely known as res-
piratory irritators [1-4]. Isocyanates are a group of aro-
matic and aliphatic compounds of low molecules weight
containing the group -N = C = O [9]. The ability to react
with acrylic polyols and therefore to form the coating
makes this compound a drying accelerator for paints and
varnishes [1]. On the other hand, many reports point out
that high concentrations of these compounds in the air,
especially of TDI, irritate and sensitize the airways of
exposed workers [4,9,11,12,16].
The most plausible immune mechanism involved in the
sensitization to di-isocyanates is the TH2 profile induc-
tion, but simultaneous induction of TH1 and CD8
responses are also reported [2,4,6,7,9,15]. Recent studies
in animal models have shown that sensitization can occur
through subchronic inhalation of di-isocyanate at levelsJournal of Occupational Medicine and Toxicology 2008, 3:29 http://www.occup-med.com/content/3/1/29
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as low as 20 ppb as well as through dermal exposure
[2,7,10,14-16,18]. Unfortunately, in Albania there is no
reliable authority to control the environmental condi-
tions of workplaces, especially in small private establish-
ments. In this respect, rigorous preventive measures are
needed [1,3].
The association of isocyanate-induced occupational
asthma and anaphylaxis to peanuts consumption has not
been described previously. Such complication of isocy-
anate-induced occupational asthma by food allergy is
reported at least in two cases and the implicated foods
were the plants of the mustard family [19,20]. The sug-
gested phys-pathological mechanism of these cases was
the cross-reactivity, as isothiocyanates are found in mus-
tard spice [19]. As long as such compounds are not seen
in peanuts, the induction of anaphylaxis due to peanut
consumption as a consequence of prior isocyanate-
induced occupational sensitization was not demon-
strated.
The association of both pathologies could be explained
with induction of TH2 immune response rather than with
induction of TH1 one. This is supported by typical clinical
findings such as the occurrence of IgE-mediated symp-
toms following peanut consumption in a subject previ-
ously diagnosed with an isocyanate-induced asthma, even
if in our case there was no laboratory evidence (because of
objective reasons) [2,4,6-9].
On the other hand, a less plausible mechanism could be
the presence of isocyanates in peanuts due to a probable
contamination by pesticides and therefore, an allergic
reaction was induced after the di-isocyanates "consump-
tion". In this respect, isocyanates such as methylisocy-
anate, used as intermediates in the synthesis of carbamate
pesticides or di-isocyanates, are highly reactive com-
pounds that spontaneously bind to biological macromol-
ecules [9,21]. Because the isocyanate peanuts
contamination has not been proven, very limited data
support this hypothesis.
Conclusion
The lack of relevant laboratory findings could be a limita-
tion for this report. Nevertheless, this case description
could be of interest, because it is possibly the first reported
case of isocyanate-induced occupational asthma in a
patient who developed symptoms of peanut allergy later
in his life. However, further detailed studies are necessary
to elucidate the questions posed in this report, in order to
take further suitable precautions.
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